140 related articles for article (PubMed ID: 38240780)
1. Thymol-loaded liposomes effectively induced apoptosis and decreased EGFR expression in colorectal cancer cells.
Keshavarz F; Soltanshahi M; Khosravani F; Bakhshiyan F; Ghanbari A; Hassanzadeh S; Amirpour M; Ghalamfarsa G
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5157-5165. PubMed ID: 38240780
[TBL] [Abstract][Full Text] [Related]
2. Quercetin-loaded Liposomes Effectively Induced Apoptosis and Decreased the Epidermal Growth Factor Receptor Expression in Colorectal Cancer Cells: An
Keshavarz F; Dorfaki M; Bardania H; Khosravani F; Nazari P; Ghalamfarsa G
Iran J Med Sci; 2023 May; 48(3):321-328. PubMed ID: 37791331
[TBL] [Abstract][Full Text] [Related]
3. Targeting of high mobility group A2 by small interfering RNA-loaded nanoliposome-induced apoptosis and migration inhibition in gastrointestinal cancer cells.
Mohammadi A; Mansoori B; Savadi P; Khaze V; Minouei M; McMillan NAJ; Hallaj-Nezhadi S; Baradaran B
J Cell Biochem; 2019 Jun; 120(6):9203-9212. PubMed ID: 30507008
[TBL] [Abstract][Full Text] [Related]
4. Nanoliposome-loaded phenolics from Salvia leriifolia Benth and its anticancer effects against induced colorectal cancer in mice.
Nasrabadi NS; Vedad A; Asadi K; Poorbagher MRM; Tabrizi NA; Dorooki K; Sabouni RS; Moghadam MB; Shafaei N; Karimi E; Oskoueian E
Biotechnol Appl Biochem; 2024 Jun; 71(3):641-650. PubMed ID: 38326022
[TBL] [Abstract][Full Text] [Related]
5. Thymol Isolated from
Zeng Q; Che Y; Zhang Y; Chen M; Guo Q; Zhang W
Drug Des Devel Ther; 2020; 14():2535-2547. PubMed ID: 32669835
[TBL] [Abstract][Full Text] [Related]
6. Lidocaine inhibits proliferation and induces apoptosis in colorectal cancer cells by upregulating mir-520a-3p and targeting EGFR.
Qu X; Yang L; Shi Q; Wang X; Wang D; Wu G
Pathol Res Pract; 2018 Dec; 214(12):1974-1979. PubMed ID: 30262429
[TBL] [Abstract][Full Text] [Related]
7. Tumor RNA-loaded nanoliposomes increases the anti-tumor immune response in colorectal cancer.
Dai D; Yin Y; Hu Y; Lu Y; Zou H; Lu G; Wang Q; Lian J; Gao J; Shen X
Drug Deliv; 2021 Dec; 28(1):1548-1561. PubMed ID: 34286631
[TBL] [Abstract][Full Text] [Related]
8. Study the Anticancer Properties of Thymol-Loaded PEGylated Bovine Serum Albumin Nanoparticles Conjugated with Folic Acid.
Al-Salih MYA; Pouresmaeil V; Davoodi-Dehaghani F; Haghighi HN; Tabrizi MH
Chem Biodivers; 2023 Nov; 20(11):e202301122. PubMed ID: 37823866
[TBL] [Abstract][Full Text] [Related]
9. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X
Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200
[TBL] [Abstract][Full Text] [Related]
10. miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway.
Niu Y; Zhang J; Tong Y; Li J; Liu B
Int J Biochem Cell Biol; 2019 Dec; 117():105641. PubMed ID: 31693935
[TBL] [Abstract][Full Text] [Related]
11. Polyvinyl Alcohol (PVA)-Based Nanoniosome for Enhanced in vitro Delivery and Anticancer Activity of Thymol.
Abdihaji M; Mirzaei Chegeni M; Hadizadeh A; Farrokhzad N; Kheradmand Z; Fakhrfatemi P; Faress F; Moeinabadi-Bidgoli K; Noorbazargan H; Mostafavi E
Int J Nanomedicine; 2023; 18():3459-3488. PubMed ID: 37396433
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-24 regulates the growth and chemosensitivity of the human colorectal cancer cells by targeting RNA-binding protein DND1.
Zhang Q; Li W; Liu G; Tang W
J BUON; 2019; 24(4):1476-1481. PubMed ID: 31646794
[TBL] [Abstract][Full Text] [Related]
13. Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer.
Sen K; Banerjee S; Mandal M
Colloids Surf B Biointerfaces; 2019 Aug; 180():9-22. PubMed ID: 31015105
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic effects of thymol, a novel monoterpene phenol, on different types of cancer.
Elbe H; Yigitturk G; Cavusoglu T; Uyanikgil Y; Ozturk F
Bratisl Lek Listy; 2020; 121(2):122-128. PubMed ID: 32115964
[TBL] [Abstract][Full Text] [Related]
15. Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines.
Vitiello PP; Cardone C; Martini G; Ciardiello D; Belli V; Matrone N; Barra G; Napolitano S; Della Corte C; Turano M; Furia M; Troiani T; Morgillo F; De Vita F; Ciardiello F; Martinelli E
J Exp Clin Cancer Res; 2019 Jan; 38(1):41. PubMed ID: 30691487
[TBL] [Abstract][Full Text] [Related]
16. Plant Phenolics Ferulic Acid and P-Coumaric Acid Inhibit Colorectal Cancer Cell Proliferation through EGFR Down-Regulation.
Roy N; Narayanankutty A; Nazeem PA; Valsalan R; Babu TD; Mathew D
Asian Pac J Cancer Prev; 2016; 17(8):4019-23. PubMed ID: 27644655
[TBL] [Abstract][Full Text] [Related]
17. Comparison of ultrastructural changes and the anticarcinogenic effects of thymol and carvacrol on ovarian cancer cells: which is more effective?
Elbe H; Yigitturk G; Cavusoglu T; Baygar T; Ozgul Onal M; Ozturk F
Ultrastruct Pathol; 2020 Mar; 44(2):193-202. PubMed ID: 32183603
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-141-3p affected proliferation, chemosensitivity, migration and invasion of colorectal cancer cells by targeting EGFR.
Xing Y; Jing H; Zhang Y; Suo J; Qian M
Int J Biochem Cell Biol; 2020 Jan; 118():105643. PubMed ID: 31704502
[TBL] [Abstract][Full Text] [Related]
19. EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients.
Srivatsa S; Paul MC; Cardone C; Holcmann M; Amberg N; Pathria P; Diamanti MA; Linder M; Timelthaler G; Dienes HP; Kenner L; Wrba F; Prager GW; Rose-John S; Eferl R; Liguori G; Botti G; Martinelli E; Greten FR; Ciardiello F; Sibilia M
Gastroenterology; 2017 Jul; 153(1):178-190.e10. PubMed ID: 28400195
[TBL] [Abstract][Full Text] [Related]
20. In vitro and ex vivo delivery of tailored siRNA-nanoliposomes for E2F1 silencing as a potential therapy for colorectal cancer.
Bochicchio S; Dapas B; Russo I; Ciacci C; Piazza O; De Smedt S; Pottie E; Barba AA; Grassi G
Int J Pharm; 2017 Jun; 525(2):377-387. PubMed ID: 28189855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
